Shanmugam Muthusamy's most recent trade in ANI Pharmaceuticals Inc was a trade of 700 Common Stock done at an average price of $76.8 . Disclosure was reported to the exchange on May 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 76.83 per share. | 09 May 2025 | 700 | 631,920 (5%) | 0% | 76.8 | 53,781 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 14,362 | 83,014 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 9,574 | 92,588 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 18 Jul 2024 | 2,743 | 632,620 (5%) | 0% | 62 | 170,066 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 64.27 per share. | 15 Jul 2024 | 22,000 | 649,620 (5%) | 0% | 64.3 | 1,413,940 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.16 per share. | 15 Jul 2024 | 14,257 | 635,363 (5%) | 0% | 63.2 | 900,472 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.38 per share. | 15 Jul 2024 | 11,000 | 671,620 (5%) | 0% | 63.4 | 697,180 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 58.90 per share. | 21 Jun 2024 | 20,000 | 682,620 (5%) | 0% | 58.9 | 1,178,000 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 59.86 per share. | 17 Jun 2024 | 11,447 | 702,620 (5%) | 0% | 59.9 | 685,217 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 60.76 per share. | 17 Jun 2024 | 10,607 | 714,067 (5%) | 0% | 60.8 | 644,481 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.41 per share. | 17 Jun 2024 | 7,946 | 724,674 (5%) | 0% | 61.4 | 487,964 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.81 per share. | 20 May 2024 | 12,855 | 732,620 (6%) | 0% | 61.8 | 794,568 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.84 per share. | 15 May 2024 | 16,459 | 751,311 (6%) | 0% | 63.8 | 1,050,743 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.86 per share. | 15 May 2024 | 14,850 | 767,770 (6%) | 0% | 65.9 | 978,021 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 62.09 per share. | 15 May 2024 | 5,836 | 745,475 (6%) | 0% | 62.1 | 362,357 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.17 per share. | 18 Apr 2024 | 16,809 | 782,620 (6%) | 0% | 65.2 | 1,095,443 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 64.98 per share. | 18 Apr 2024 | 10,423 | 799,429 (6%) | 0% | 65.0 | 677,287 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.40 per share. | 15 Apr 2024 | 9,520 | 809,852 (6%) | 0% | 65.4 | 622,608 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 66.33 per share. | 15 Apr 2024 | 7,414 | 825,206 (6%) | 0% | 66.3 | 491,771 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 66.20 per share. | 15 Apr 2024 | 5,834 | 819,372 (6%) | 0% | 66.2 | 386,211 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 67.17 per share. | 08 Mar 2024 | 10,000 | 832,620 (6%) | 0% | 67.2 | 671,700 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 66.35 per share. | 05 Mar 2024 | 15,085 | 842,620 (6%) | 0% | 66.4 | 1,000,890 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.47 per share. | 05 Mar 2024 | 14,822 | 857,705 (7%) | 0% | 65.5 | 970,396 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 65.35 per share. | 05 Mar 2024 | 10,093 | 872,527 (7%) | 0% | 65.4 | 659,578 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,122 | 68,652 (0%) | 0% | 67.7 | 75,926 | Common Stock |
| ANI Pharmaceuticals Inc | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 13,421 | 60,828 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 8,946 | 69,774 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 56.44 per share. | 19 Jan 2024 | 15,000 | 882,620 (7%) | 0% | 56.4 | 846,600 | Common Stock |
| ANI Pharmaceuticals Inc | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.95 per share. | 19 Jan 2024 | 5,692 | 897,620 (7%) | 0% | 55.9 | 318,467 | Common Stock |
| ANI Pharmaceuticals Inc | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.57 per share. | 19 Jan 2024 | 4,524 | 903,312 (7%) | 0% | 55.6 | 251,399 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.11 per share. | 16 Jan 2024 | 10,000 | 917,620 (7%) | 0% | 55.1 | 551,100 | Common Stock |
| ANI Pharmaceuticals Inc | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 16 Jan 2024 | 9,784 | 907,836 (7%) | 0% | 55.3 | 541,055 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 55.63 per share. | 16 Jan 2024 | 5,000 | 927,620 (7%) | 0% | 55.6 | 278,150 | Common Stock |
| ANI Pharmaceuticals Inc | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.65 per share. | 15 Dec 2023 | 25,000 | 932,620 (7%) | 0% | 52.7 | 1,316,250 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.44 per share. | 15 Dec 2023 | 13,026 | 957,620 (7%) | 0% | 52.4 | 683,083 | Common Stock |
| ANI Pharmaceuticals Inc | Shanmugam Muthusamy | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.44 per share. | 15 Dec 2023 | 11,974 | 970,646 (8%) | 0% | 52.4 | 627,917 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.06 per share. | 28 Aug 2023 | 25,000 | 1,157,620 (9%) | 0% | 63.1 | 1,576,500 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 63.37 per share. | 28 Aug 2023 | 25,000 | 1,132,620 (9%) | 0% | 63.4 | 1,584,250 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.15 per share. | 14 Aug 2023 | 27,890 | 1,204,730 (9%) | 0% | 61.2 | 1,705,474 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 61.60 per share. | 14 Aug 2023 | 22,110 | 1,182,620 (9%) | 0% | 61.6 | 1,361,976 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 52.56 per share. | 19 Jul 2023 | 11,500 | 1,232,620 (10%) | 0% | 52.6 | 604,440 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.52 per share. | 19 Jul 2023 | 6,000 | 1,244,120 (10%) | 0% | 51.5 | 309,120 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.48 per share. | 19 Jul 2023 | 5,969 | 1,250,120 (10%) | 0% | 51.5 | 307,284 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 50.43 per share. | 14 Jul 2023 | 10,000 | 1,272,620 (10%) | 0% | 50.4 | 504,300 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.06 per share. | 14 Jul 2023 | 9,831 | 1,262,789 (10%) | 0% | 51.1 | 501,971 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.84 per share. | 14 Jul 2023 | 6,700 | 1,256,089 (10%) | 0% | 51.8 | 347,328 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.93 per share. | 20 Jun 2023 | 14,657 | 32,750 (0%) | 0% | 51.9 | 761,138 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.38 per share. | 20 Jun 2023 | 13,500 | 7,407 (0%) | 0% | 51.4 | 693,630 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Sale of securities on an exchange or to another person at price $ 51.95 per share. | 20 Jun 2023 | 11,843 | 20,907 (0%) | 0% | 52.0 | 615,244 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 35,829 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 47,407 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Purchase of securities on an exchange or from another person at price $ 27.65 per share. | 17 Mar 2022 | 5,000 | 5,000 (0%) | 0% | 27.7 | 138,252 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Purchase of securities on an exchange or from another person at price $ 27.65 per share. | 17 Mar 2022 | 5,000 | 18,460 (0%) | 0% | 27.7 | 138,252 | Common Stock |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 1,332,620 | 1,332,620 (11%) | 11% | - | Common Stock | |
| ANI Pharmaceuticals Inc | Muthusamy Shanmugam | Director, HEAD OF R&D, COO-NOVITIUM OPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 13,460 | 13,460 (0%) | 0% | - | Common Stock |